Targeting chemokine (C-C motif) Ligand 2 (CCL2) as an example of translation of cancer molecular biology to the clinic

Progress in Molecular Biology and Translational Science

Volumn 95, Issue C, 2010, Pages 31-53

  Zhang, Jian ^a,b   Patel, Lalit ^a,b   Pienta, Kenneth J ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78649291412     PISSN: 18771173     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-385071-3.00003-4     Document Type: Chapter

References (155)

1. T. Yoshimura, E.A. Robinson, S. Tanaka, E. Appella, J. Kuratsu, and E.J. Leonard Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants J Exp Med 169 1989 1449 1459
2. K. Matsushima, C.G. Larsen, G.C. DuBois, and J.J. Oppenheim Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line J Exp Med 169 1989 1485 1490
3. F. Balkwill Cancer and the chemokine network Nat Rev Cancer 4 2004 540 550
4. I.F. Charo, and M.B. Taubman Chemokines in the pathogenesis of vascular disease Circ Res 95 2004 858 866
5. B.H. Cochran, A.C. Reffel, and C.D. Stiles Molecular cloning of gene sequences regulated by platelet-derived growth factor Cell 33 1983 939 947
6. E. Van Coillie, J. Van Damme, and G. Opdenakker The MCP/eotaxin subfamily of CC chemokines Cytokine Growth Factor Rev 10 1999 61 86
7. D.T. Graves, Y. Jiang, and A.J. Valente Regulated expression of MCP-1 by osteoblastic cells in vitro and in vivo Histol Histopathol 14 1999 1347 1354
8. S.L. Deshmane, S. Kremlev, S. Amini, and B.E. Sawaya Monocyte chemoattractant protein-1 (MCP-1): an overview J Interferon Cytokine Res 29 2009 313 326
9. B.P. Barna, J. Pettay, G.H. Barnett, P. Zhou, K. Iwasaki, and M.L. Estes Regulation of monocyte chemoattractant protein-1 expression in adult human non-neoplastic astrocytes is sensitive to tumor necrosis factor (TNF) or antibody to the 55-kDa TNF receptor J Neuroimmunol 50 1994 101 107
10. Z. Brown, R.M. Strieter, G.H. Neild, R.C. Thompson, S.L. Kunkel, and J. Westwick IL-1 receptor antagonist inhibits monocyte chemotactic peptide 1 generation by human mesangial cells Kidney Int 42 1992 95 101
11. S.D. Cushing, J.A. Berliner, A.J. Valente, M.C. Territo, M. Navab, and F. Parhami Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells Proc Natl Acad Sci USA 87 1990 5134 5138
12. T.J. Standiford, S.L. Kunkel, S.H. Phan, B.J. Rollins, and R.M. Strieter Alveolar macrophage-derived cytokines induce monocyte chemoattractant protein-1 expression from human pulmonary type II-like epithelial cells J Biol Chem 266 1991 9912 9918
13. Y. Lu, G. Xiao, D.L. Galson, Y. Nishio, A. Mizokami, and E.T. Keller PTHrP-induced MCP-1 production by human bone marrow endothelial cells and osteoblasts promotes osteoclast differentiation and prostate cancer cell proliferation and invasion in vitro Int J Cancer 121 2007 724 733
14. T. Yoshimura, N. Yuhki, S.K. Moore, E. Appella, M.I. Lerman, and E.J. Leonard Human monocyte chemoattractant protein-1 (MCP-1). Full-length cDNA cloning, expression in mitogen-stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE FEBS Lett 244 1989 487 493
15. J. Zhang, L. Patel, and K.J. Pienta CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasis Cytokine Growth Factor Rev 21 2010 41 48
16. J. Zhang, Y. Lu, and K.J. Pienta Multiple roles of chemokine (C-C motif) ligand 2 in promoting prostate cancer growth J Natl Cancer Inst 102 2010 522 528
17. M.J. Craig, and R.D. Loberg CCL2 (Monocyte Chemoattractant Protein-1) in cancer bone metastases Cancer Metastasis Rev 25 2006 611 619
18. Y. Lu, Z. Cai, D.L. Galson, G. Xiao, Y. Liu, and D.E. George Monocyte chemotactic protein-1 (MCP-1) acts as a paracrine and autocrine factor for prostate cancer growth and invasion Prostate 66 2006 1311 1318
19. L. Mazzucchelli, P. Loetscher, A. Kappeler, M. Uguccioni, M. Baggiolini, and J.A. Laissue Monocyte chemoattractant protein-1 gene expression in prostatic hyperplasia and prostate adenocarcinoma Am J Pathol 149 1996 501 509
20. A. Chetcuti, S. Margan, S. Mann, P. Russell, D. Handelsman, and J. Rogers Identification of differentially expressed genes in organ-confined prostate cancer by gene expression array Prostate 47 2001 132 140
21. R.D. Loberg, L.L. Day, J. Harwood, C. Ying, L.N. St John, and R. Giles CCL2 is a potent regulator of prostate cancer cell migration and proliferation Neoplasia 8 2006 578 586
22. S. Stifter The role of nuclear factor kappaB on angiogenesis regulation through monocyte chemotactic protein-1 in myeloma Med Hypotheses 66 2006 384 386
23. A.A. Hurwitz, W.D. Lyman, and J.W. Berman Tumor necrosis factor alpha and transforming growth factor beta upregulate astrocyte expression of monocyte chemoattractant protein-1 J Neuroimmunol 57 1995 193 198
24. K. Johrer, K. Janke, J. Krugmann, M. Fiegl, and R. Greil Transendothelial migration of myeloma cells is increased by tumor necrosis factor (TNF)-alpha via TNF receptor 2 and autocrine up-regulation of MCP-1 Clin Cancer Res 10 2004 1901 1910
25. M.S. Kim, C.J. Day, and N.A. Morrison MCP-1 is induced by receptor activator of nuclear factor-{kappa}B ligand, promotes human osteoclast fusion, and rescues granulocyte macrophage colony-stimulating factor suppression of osteoclast formation J Biol Chem 280 2005 16163 16169
26. F. Balkwill Chemokine biology in cancer Semin Immunol 15 2003 49 55
27. T. Kurihara, G. Warr, J. Loy, and R. Bravo Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor J Exp Med 186 1997 1757 1762
28. M.N. Ajuebor, R.J. Flower, R. Hannon, M. Christie, K. Bowers, and A. Verity Endogenous monocyte chemoattractant protein-1 recruits monocytes in the zymosan peritonitis model J Leukoc Biol 63 1998 108 116
29. I. Kurth, K. Willimann, P. Schaerli, T. Hunziker, I. Clark-Lewis, and B. Moser Monocyte selectivity and tissue localization suggests a role for breast and kidney-expressed chemokine (BRAK) in macrophage development J Exp Med 194 2001 855 861
30. S.W. Chensue, K.S. Warmington, N.W. Lukacs, P.M. Lincoln, M.D. Burdick, and R.M. Strieter Monocyte chemotactic protein expression during schistosome egg granuloma formation. Sequence of production, localization, contribution, and regulation Am J Pathol 146 1995 130 138
31. S.W. Chensue, K.S. Warmington, J.H. Ruth, P.S. Sanghi, P. Lincoln, and S.L. Kunkel Role of monocyte chemoattractant protein-1 (MCP-1) in Th1 (mycobacterial) and Th2 (schistosomal) antigen-induced granuloma formation: relationship to local inflammation, Th cell expression, and IL-12 production J Immunol 157 1996 4602 4608
32. T.M. Handel, and P.J. Domaille Heteronuclear (1H, 13C, 15N) NMR assignments and solution structure of the monocyte chemoattractant protein-1 (MCP-1) dimer Biochemistry 35 1996 6569 6584
33. J.A. Gonzalo, C.M. Lloyd, D. Wen, J.P. Albar, T.N. Wells, and A. Proudfoot The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness J Exp Med 188 1998 157 167
34. L. Gu, S. Tseng, R.M. Horner, C. Tam, M. Loda, and B.J. Rollins Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1 Nature 404 2000 407 411
35. W.J. Karpus, N.W. Lukacs, K.J. Kennedy, W.S. Smith, S.D. Hurst, and T.A. Barrett Differential CC chemokine-induced enhancement of T helper cell cytokine production J Immunol 158 1997 4129 4136
36. O. Dewald, P. Zymek, K. Winkelmann, A. Koerting, G. Ren, and T. Abou-Khamis CCL2/monocyte chemoattractant protein-1 regulates inflammatory responses critical to healing myocardial infarcts Circ Res 96 2005 881 889
37. L. Boring, J. Gosling, M. Cleary, and I.F. Charo Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis Nature 394 1998 894 897
38. M. Namiki, S. Kawashima, T. Yamashita, M. Ozaki, T. Hirase, and T. Ishida Local overexpression of monocyte chemoattractant protein-1 at vessel wall induces infiltration of macrophages and formation of atherosclerotic lesion: synergism with hypercholesterolemia Arterioscler Thromb Vasc Biol 22 2002 115 120
39. L. Izikson, R.S. Klein, I.F. Charo, H.L. Weiner, and A.D. Luster Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2 J Exp Med 192 2000 1075 1080
40. S. Shahrara, A.E. Proudfoot, C.C. Park, M.V. Volin, G.K. Haines, and J.M. Woods Inhibition of monocyte chemoattractant protein-1 ameliorates rat adjuvant-induced arthritis J Immunol 180 2008 3447 3456
41. T. Wada, H. Yokoyama, K. Furuichi, K.I. Kobayashi, K. Harada, and M. Naruto Intervention of crescentic glomerulonephritis by antibodies to monocyte chemotactic and activating factor (MCAF/MCP-1) FASEB J 10 1996 1418 1425
42. Y. Kasahara, H. Kimura, K. Kurosu, K. Sugito, N. Mukaida, and K. Matsushima MCAF/MCP-1 protein expression in a rat model for pulmonary hypertension induced by monocrotaline Chest 114 1998 67S
43. B.B. Moore, R. Paine 3rd, P.J. Christensen, T.A. Moore, S. Sitterding, and R. Ngan Protection from pulmonary fibrosis in the absence of CCR2 signaling J Immunol 167 2001 4368 4377
44. S. Volejnikova, M. Laskari, S.C. Marks Jr., and D.T. Graves Monocyte recruitment and expression of monocyte chemoattractant protein-1 are developmentally regulated in remodeling bone in the mouse Am J Pathol 150 1997 1711 1721
45. M.S. Kim, C.J. Day, C.I. Selinger, C.L. Magno, S.R. Stephens, and N.A. Morrison MCP-1-induced human osteoclast-like cells are tartrate-resistant acid phosphatase, NFATc1, and calcitonin receptor-positive but require receptor activator of NFkappaB ligand for bone resorption J Biol Chem 281 2006 1274 1285
46. R. Alam, D. Kumar, D. Anderson-Walters, and P.A. Forsythe Macrophage inflammatory protein-1 alpha and monocyte chemoattractant peptide-1 elicit immediate and late cutaneous reactions and activate murine mast cells in vivo J Immunol 152 1994 1298 1303
47. D. Taub, J. Dastych, N. Inamura, J. Upton, D. Kelvin, and D. Metcalfe Bone marrow-derived murine mast cells migrate, but do not degranulate, in response to chemokines J Immunol 154 1995 2393 2402
48. P. Valent Cytokines involved in growth and differentiation of human basophils and mast cells Exp Dermatol 4 1995 255 259
49. J.W. Pollard Tumour-educated macrophages promote tumour progression and metastasis Nat Rev Cancer 4 2004 71 78
50. Y. Kim, S. Sung, W.A. Kuziel, S. Feldman, S.M. Fu, and C.E. Rose Jr. Enhanced airway Th2 response after allergen challenge in mice deficient in CC chemokine receptor-2 (CCR2) J Immunol 166 2001 5183 5192
51. R. Salcedo, M.L. Ponce, H.A. Young, K. Wasserman, J.M. Ward, and H.K. Kleinman Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression Blood 96 2000 34 40
52. M.T. Carulli, V.H. Ong, M. Ponticos, X. Shiwen, D.J. Abraham, and C.M. Black Chemokine receptor CCR2 expression by systemic sclerosis fibroblasts: evidence for autocrine regulation of myofibroblast differentiation Arthritis Rheum 52 2005 3772 3782
53. A.H. Klopp, E.L. Spaeth, J.L. Dembinski, W.A. Woodward, A. Munshi, and R.E. Meyn Tumor irradiation increases the recruitment of circulating mesenchymal stem cells into the tumor microenvironment Cancer Res 67 2007 11687 11695
54. Y. Lu, Z. Cai, G. Xiao, Y. Liu, E.T. Keller, and Z. Yao CCR2 expression correlates with prostate cancer progression J Cell Biochem 101 2007 676 685
55. R.D. Loberg, C. Ying, M. Craig, L.L. Day, E. Sargent, and C. Neeley Targeting CCL2 with systemic delivery of neutralizing antibodies induces prostate cancer tumor regression in vivo Cancer Res 67 2007 9417 9424
56. M. Xia, and Z. Sui Recent developments in CCR2 antagonists Expert Opin Ther Pat 19 2009 295 303
57. N.B. Binder, B. Niederreiter, O. Hoffmann, R. Stange, T. Pap, and T.M. Stulnig Estrogen-dependent and C-C chemokine receptor-2-dependent pathways determine osteoclast behavior in osteoporosis Nat Med 15 2009 417 424
58. Y. Lu, Q. Chen, E. Corey, W. Xie, J. Fan, and A. Mizokami Activation of MCP-1/CCR2 axis promotes prostate cancer growth in bone Clin Exp Metastasis 26 2009 161 169
59. H. Juppner, A.B. Abou-Samra, M. Freeman, X.F. Kong, E. Schipani, and J. Richards A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide Science 254 1991 1024 1026
60. W.J. Burtis Parathyroid hormone-related protein: structure, function, and measurement Clin Chem 38 1992 2171 2183
61. K.M. Dougherty, E.A. Blomme, A.J. Koh, J.E. Henderson, K.J. Pienta, and T.J. Rosol Parathyroid hormone-related protein as a growth regulator of prostate carcinoma Cancer Res 59 1999 6015 6022
62. M. Iwamura, P.A. di Sant'Agnese, G. Wu, C.M. Benning, A.T. Cockett, and L.J. Deftos Immunohistochemical localization of parathyroid hormone-related protein in human prostate cancer Cancer Res 53 1993 1724 1726
63. M. Iwamura, S. Gershagen, O. Lapets, R. Moynes, P.A. Abrahamsson, and A.T. Cockett Immunohistochemical localization of parathyroid hormone-related protein in prostatic intraepithelial neoplasia Hum Pathol 26 1995 797 801
64. L.J. Deftos, I. Barken, D.W. Burton, R.M. Hoffman, and J. Geller Direct evidence that PTHrP expression promotes prostate cancer progression in bone Biochem Biophys Res Commun 327 2005 468 472
65. T.A. Guise, J.J. Yin, R.J. Thomas, M. Dallas, Y. Cui, and M.T. Gillespie Parathyroid hormone-related protein (PTHrP)-(1-139) isoform is efficiently secreted in vitro and enhances breast cancer metastasis to bone in vivo Bone 30 2002 670 676
66. J.J. Yin, K. Selander, J.M. Chirgwin, M. Dallas, B.G. Grubbs, and R. Wieser TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development J Clin Invest 103 1999 197 206
67. M.E. Dunbar, and J.J. Wysolmerski Parathyroid hormone-related protein: a developmental regulatory molecule necessary for mammary gland development J Mammary Gland Biol Neoplasia 4 1999 21 34
68. Z. Bouizar, F. Spyratos, and M.C. De vernejoul The parathyroid hormone-related protein (PTHrP) gene: use of downstream TATA promotor and PTHrP 1-139 coding pathways in primary breast cancers vary with the occurrence of bone metastasis J Bone Miner Res 14 1999 406 414
69. X. Li, L. Qin, M. Bergenstock, L.M. Bevelock, D.V. Novack, and N.C. Partridge Parathyroid hormone stimulates osteoblastic expression of MCP-1 to recruit and increase the fusion of pre/osteoclasts J Biol Chem 282 2007 33098 33106
70. J. Liao, X. Li, A.J. Koh, J.E. Berry, N. Thudi, and T.J. Rosol Tumor expressed PTHrP facilitates prostate cancer-induced osteoblastic lesions Int J Cancer 123 2008 2267 2278
71. X. Li, R. Loberg, J. Liao, C. Ying, L.A. Snyder, and K.J. Pienta A destructive cascade mediated by CCL2 facilitates prostate cancer growth in bone Cancer Res 69 2009 1685 1692
72. O. Sekine, Y. Nishio, K. Egawa, T. Nakamura, H. Maegawa, and A. Kashiwagi Insulin activates CCAAT/enhancer binding proteins and proinflammatory gene expression through the phosphatidylinositol 3-kinase pathway in vascular smooth muscle cells J Biol Chem 277 2002 36631 36639
73. A. Ueda, K. Okuda, S. Ohno, A. Shirai, T. Igarashi, and K. Matsunaga NF-kappa B and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene J Immunol 153 1994 2052 2063
74. E.D. Milligan, C. Twining, M. Chacur, J. Biedenkapp, K. O'Connor, and S. Poole Spinal glia and proinflammatory cytokines mediate mirror-image neuropathic pain in rats J Neurosci 23 2003 1026 1040
75. C.M. Twining, E.M. Sloane, E.D. Milligan, M. Chacur, D. Martin, and S. Poole Peri-sciatic proinflammatory cytokines, reactive oxygen species, and complement induce mirror-image neuropathic pain in rats Pain 110 2004 299 309
76. H. Jung, and R.J. Miller Activation of the nuclear factor of activated T-cells (NFAT) mediates upregulation of CCR2 chemokine receptors in dorsal root ganglion (DRG) neurons: a possible mechanism for activity-dependent transcription in DRG neurons in association with neuropathic pain Mol Cell Neurosci 37 2008 170 177
77. D.Z. Qian, B.L. Rademacher, J. Pittsenbarger, C.Y. Huang, A. Myrthue, and C.S. Higano CCL2 is induced by chemotherapy and protects prostate cancer cells from docetaxel-induced cytotoxicity Prostate 70 2010 433 442
78. R.J. Phillips, M. Lutz, and B. Premack Differential signaling mechanisms regulate expression of CC chemokine receptor-2 during monocyte maturation J Inflamm (Lond) 2 2005 14
79. Y. Chen, S.R. Green, J. Ho, A. Li, F. Almazan, and O. Quehenberger The mouse CCR2 gene is regulated by two promoters that are responsive to plasma cholesterol and peroxisome proliferator-activated receptor gamma ligands Biochem Biophys Res Commun 332 2005 188 193
80. A.R. Glabinski, B. Bielecki, P. Kolodziejski, Y. Han, K. Selmaj, and R.M. Ransohoff TNF-alpha microinjection upregulates chemokines and chemokine receptors in the central nervous system without inducing leukocyte infiltration J Interferon Cytokine Res 23 2003 457 466
81. K. Yamamoto, H. Takeshima, K. Hamada, M. Nakao, T. Kino, and T. Nishi Cloning and functional characterization of the 5′-flanking region of the human monocyte chemoattractant protein-1 receptor (CCR2) gene. Essential role of 5′-untranslated region in tissue-specific expression J Biol Chem 274 1999 4646 4654
82. C.R. Raymond, S.J. Redman, and M.F. Crouch The phosphoinositide 3-kinase and p70 S6 kinase regulate long-term potentiation in hippocampal neurons Neuroscience 109 2002 531 536
83. M.A. Gavrilin, I.V. Gulina, T. Kawano, S. Dragan, L. Chakravarti, and P.E. Kolattukudy Site-directed mutagenesis of CCR2 identified amino acid residues in transmembrane helices 1, 2, and 7 important for MCP-1 binding and biological functions Biochem Biophys Res Commun 327 2005 533 540
84. Y. Terashima, N. Onai, M. Murai, M. Enomoto, V. Poonpiriya, and T. Hamada Pivotal function for cytoplasmic protein FROUNT in CCR2-mediated monocyte chemotaxis Nat Immunol 6 2005 827 835
85. M. Satoh, T. Akatsu, Y. Ishkawa, Y. Minami, and M. Nakamura A novel activator of C-C chemokine, FROUNT, is expressed with C-C chemokine receptor 2 and its ligand in failing human heart J Card Fail 13 2007 114 119
86. P.K. Majumder, and W.R. Sellers Akt-regulated pathways in prostate cancer Oncogene 24 2005 7465 7474
87. X. Zi, R.P. Singh, and R. Agarwal Impairment of erbB1 receptor and fluid-phase endocytosis and associated mitogenic signaling by inositol hexaphosphate in human prostate carcinoma DU145 cells Carcinogenesis 21 2000 2225 2235
88. H. Miyake, C. Nelson, P.S. Rennie, and M.E. Gleave Overexpression of insulin-like growth factor binding protein-5 helps accelerate progression to androgen-independence in the human prostate LNCaP tumor model through activation of phosphatidylinositol 3′-kinase pathway Endocrinology 141 2000 2257 2265
89. H. Murillo, H. Huang, L.J. Schmidt, D.I. Smith, and D.J. Tindall Role of PI3K signaling in survival and progression of LNCaP prostate cancer cells to the androgen refractory state Endocrinology 142 2001 4795 4805
90. H. Roca, Z. Varsos, and K.J. Pienta CCL2 protects prostate cancer PC3 cells from autophagic death via phosphatidylinositol 3-kinase/AKT-dependent survivin up-regulation J Biol Chem 283 2008 25057 25073
91. H. Roca, Z.S. Varsos, K. Mizutani, and K.J. Pienta CCL2, survivin and autophagy: new links with implications in human cancer Autophagy 4 2008 969 971
92. H. Roca, Z.S. Varsos, and K.J. Pienta CCL2 is a negative regulator of AMP-activated protein kinase to sustain mTOR complex-1 activation, survivin expression, and cell survival in human prostate cancer PC3 cells Neoplasia 11 2009 1309 1317
93. A.E. Karnoub, and R.A. Weinberg Chemokine networks and breast cancer metastasis Breast Dis 26 2006 75 85
94. T. Ueno, M. Toi, H. Saji, M. Muta, H. Bando, and K. Kuroi Significance of macrophage chemoattractant protein-1 in macrophage recruitment, angiogenesis, and survival in human breast cancer Clin Cancer Res 6 2000 3282 3289
95. E. Nakashima, N. Mukaida, Y. Kubota, K. Kuno, K. Yasumoto, and F. Ichimura Human MCAF gene transfer enhances the metastatic capacity of a mouse cachectic adenocarcinoma cell line in vivo Pharm Res 12 1995 1598 1604
96. T. Valkovic, F. Dobrila, M. Melato, F. Sasso, C. Rizzardi, and N. Jonjic Correlation between vascular endothelial growth factor, angiogenesis, and tumor-associated macrophages in invasive ductal breast carcinoma Virchows Arch 440 2002 583 588
97. R.D. Loberg, C. Ying, M. Craig, L. Yan, L.A. Snyder, and K.J. Pienta CCL2 as an important mediator of prostate cancer growth in vivo through the regulation of macrophage infiltration Neoplasia 9 2007 556 562
98. G.D. Roodman Mechanisms of bone metastasis N Engl J Med 350 2004 1655 1664
99. G.R. Mundy Metastasis to bone: causes, consequences and therapeutic opportunities Nat Rev Cancer 2 2002 584 593
100. R.S. Taichman, R.D. Loberg, R. Mehra, and K.J. Pienta The evolving biology and treatment of prostate cancer J Clin Invest 117 2007 2351 2361
101. E.T. Keller, J. Zhang, C.R. Cooper, P.C. Smith, L.K. McCauley, and K.J. Pienta Prostate carcinoma skeletal metastases: cross-talk between tumor and bone Cancer Metastasis Rev 20 2001 333 349
102. X. Lu, and Y. Kang Organotropism of breast cancer metastasis J Mammary Gland Biol Neoplasia 12 2007 153 162
103. M. Akhtari, J. Mansuri, K.A. Newman, T.M. Guise, and P. Seth Biology of breast cancer bone metastasis Cancer Biol Ther 7 2008 3 9
104. C. Morrissey, and R.L. Vessella The role of tumor microenvironment in prostate cancer bone metastasis J Cell Biochem 101 2007 873 886
105. K. Vanderkerken, I. Vande Broek, D.L. Eizirik, E. Van Valckenborgh, K. Asosingh, and I. Van Riet Monocyte chemoattractant protein-1 (MCP-1), secreted by bone marrow endothelial cells, induces chemoattraction of 5T multiple myeloma cells Clin Exp Metastasis 19 2002 87 90
106. I. Vande Broek, K. Asosingh, K. Vanderkerken, N. Straetmans, B. Van Camp, and I. Van Riet Chemokine receptor CCR2 is expressed by human multiple myeloma cells and mediates migration to bone marrow stromal cell-produced monocyte chemotactic proteins MCP-1, -2 and -3 Br J Cancer 88 2003 855 862
107. H. Hu, L. Sun, C. Guo, Q. Liu, Z. Zhou, and L. Peng Tumor cell-microenvironment interaction models coupled with clinical validation reveal CCL2 and SNCG as two predictors of colorectal cancer hepatic metastasis Clin Cancer Res 15 2009 5485 5493
108. L.M. Coussens, and Z. Werb Inflammation and cancer Nature 420 2002 860 867
109. A.M. DeMarzo, W.G. Nelson, W.B. Isaacs, and J.I. Epstein Pathological and molecular aspects of prostate cancer Lancet 361 2003 955 964
110. A. Sica, T. Schioppa, A. Mantovani, and P. Allavena Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy Eur J Cancer 42 2006 717 727
111. A. Mantovani, B. Bottazzi, F. Colotta, S. Sozzani, and L. Ruco The origin and function of tumor-associated macrophages Immunol Today 13 1992 265 270
112. F. Balkwill, K.A. Charles, and A. Mantovani Smoldering and polarized inflammation in the initiation and promotion of malignant disease Cancer Cell 7 2005 211 217
113. P. Allavena, A. Sica, G. Solinas, C. Porta, and A. Mantovani The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages Crit Rev Oncol Hematol 66 2008 1 9
114. C. Murdoch, M. Muthana, S.B. Coffelt, and C.E. Lewis The role of myeloid cells in the promotion of tumour angiogenesis Nat Rev Cancer 8 2008 618 631
115. A. Mantovani La mala educacion of tumor-associated macrophages: diverse pathways and new players Cancer Cell 17 2010 111 112
116. G. Solinas, G. Germano, A. Mantovani, and P. Allavena Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation J Leukoc Biol 86 2009 1065 1073
117. F. Balkwill, and A. Mantovani Inflammation and cancer: back to Virchow? Lancet 357 2001 539 545
118. L. Bingle, N.J. Brown, and C.E. Lewis The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies J Pathol 196 2002 254 265
119. C. Brigati, D.M. Noonan, A. Albini, and R. Benelli Tumors and inflammatory infiltrates: friends or foes? Clin Exp Metastasis 19 2002 247 258
120. A. Mantovani, S. Sozzani, M. Locati, P. Allavena, and A. Sica Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes Trends Immunol 23 2002 549 555
121. A. Mantovani Tumor-associated macrophages in neoplastic progression: a paradigm for the in vivo function of chemokines Lab Invest 71 1994 5 16
122. H. Roca, Z.S. Varsos, S. Sud, M.J. Craig, C. Ying, and K.J. Pienta CCL2 and interleukin-6 promote survival of human CD11b+ peripheral blood mononuclear cells and induce M2-type macrophage polarization J Biol Chem 284 2009 34342 34354
123. E.Y. Lin, V. Gouon-Evans, A.V. Nguyen, and J.W. Pollard The macrophage growth factor CSF-1 in mammary gland development and tumor progression J Mammary Gland Biol Neoplasia 7 2002 147 162
124. K. Mizutani, H. Roca, Z. Varsos, and K.J. Pienta Possible mechanism of CCL2-induced Akt activation in prostate cancer cells Anticancer Res 29 2009 3109 3113
125. X. Lu, and Y. Kang Chemokine (C-C motif) ligand 2 engages CCR2+ stromal cells of monocytic origin to promote breast cancer metastasis to lung and bone J Biol Chem 284 2009 29087 29096
126. J.C. Pahler, S. Tazzyman, N. Erez, Y.Y. Chen, C. Murdoch, and H. Nozawa Plasticity in tumor-promoting inflammation: impairment of macrophage recruitment evokes a compensatory neutrophil response Neoplasia 10 2008 329 340
127. S. Eisold, J. Schmidt, E. Ryschich, M. Gock, E. Klar, and M. von Knebel Doeberitz Induction of an antitumoral immune response by wild-type adeno-associated virus type 2 in an in vivo model of pancreatic carcinoma Pancreas 35 2007 63 72
128. V. Gocheva, H.W. Wang, B.B. Gadea, T. Shree, K.E. Hunter, and A.L. Garfall IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion Genes Dev 24 2010 241 255
129. B.K. Popivanova, K. Kitamura, Y. Wu, T. Kondo, T. Kagaya, and S. Kaneko Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis J Clin Invest 118 2008 560 570
130. R.T. Palframan, S. Jung, G. Cheng, W. Weninger, Y. Luo, and M. Dorf Inflammatory chemokine transport and presentation in HEV: a remote control mechanism for monocyte recruitment to lymph nodes in inflamed tissues J Exp Med 194 2001 1361 1373
131. Z. Brown, R.L. Robson, and J. Westwick Regulation and expression of chemokines: potential role in glomerulonephritis J Leukoc Biol 59 1996 75 80
132. U. Haberstroh, K. Stilo, J. Pocock, G. Wolf, U. Helmchen, and U. Wenzel L-arginine suppresses lipopolysaccharide-induced expression of RANTES in glomeruli J Am Soc Nephrol 9 1998 203 210
133. C.O. Zachariae, A.O. Anderson, H.L. Thompson, E. Appella, A. Mantovani, and J.J. Oppenheim Properties of monocyte chemotactic and activating factor (MCAF) purified from a human fibrosarcoma cell line J Exp Med 171 1990 2177 2182
134. T.J. Martin, and G.R. Mundy Bone metastasis: can osteoclasts be excluded? Nature 445 2007 E19 [Discussion E-20]
135. T.R. Kyriakides, M.J. Foster, G.E. Keeney, A. Tsai, C.M. Giachelli, and I. Clark-Lewis The CC chemokine ligand, CCL2/MCP1, participates in macrophage fusion and foreign body giant cell formation Am J Pathol 165 2004 2157 2166
136. D.S. Steinbrech, B.J. Mehrara, P.B. Saadeh, J.A. Greenwald, J.A. Spector, and G.K. Gittes VEGF expression in an osteoblast-like cell line is regulated by a hypoxia response mechanism Am J Physiol Cell Physiol 278 2000 C853 C860
137. A. Dovio, V. Data, and A. Angeli Circulating osteoprotegerin and soluble RANKL: do they have a future in clinical practice? J Endocrinol Invest 28 2005 14 22
138. Y. Lu, Z. Cai, G. Xiao, E.T. Keller, A. Mizokami, and Z. Yao Monocyte chemotactic protein-1 mediates prostate cancer-induced bone resorption Cancer Res 67 2007 3646 3653
139. K. Mizutani, S. Sud, and K.J. Pienta Prostate cancer promotes CD11b positive cells to differentiate into osteoclasts J Cell Biochem 106 2009 563 569
140. K. Mizutani, S. Sud, N.A. McGregor, G. Martinovski, B.T. Rice, and M.J. Craig The chemokine CCL2 increases prostate tumor growth and bone metastasis through macrophage and osteoclast recruitment Neoplasia 11 2009 1235 1242
141. Z. Cai, Q. Chen, J. Chen, Y. Lu, G. Xiao, and Z. Wu Monocyte chemotactic protein 1 promotes lung cancer-induced bone resorptive lesions in vivo Neoplasia 11 2009 228 236
142. J. Zhang, L. Patel, and K.J. Pienta CC chemokine ligand 2 (CCL2) promotes prostate cancer tumorigenesis and metastasis Cytokine Growth Factor Rev 21 2009 41 48
143. X. Yang, P. Lu, Y. Ishida, W.A. Kuziel, C. Fujii, and N. Mukaida Attenuated liver tumor formation in the absence of CCR2 with a concomitant reduction in the accumulation of hepatic stellate cells, macrophages and neovascularization Int J Cancer 118 2006 335 345
144. S. Halin, S.H. Rudolfsson, N. Van Rooijen, and A. Bergh Extratumoral macrophages promote tumor and vascular growth in an orthotopic rat prostate tumor model Neoplasia 11 2009 177 186
145. S. Gazzaniga, A.I. Bravo, A. Guglielmotti, N. van Rooijen, F. Maschi, and A. Vecchi Targeting tumor-associated macrophages and inhibition of MCP-1 reduce angiogenesis and tumor growth in a human melanoma xenograft J Invest Dermatol 127 2007 2031 2041
146. S.M. Zeisberger, B. Odermatt, C. Marty, A.H. Zehnder-Fjallman, K. Ballmer-Hofer, and R.A. Schwendener Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approach Br J Cancer 95 2006 272 281
147. Y.N. Kimura, K. Watari, A. Fotovati, F. Hosoi, K. Yasumoto, and H. Izumi Inflammatory stimuli from macrophages and cancer cells synergistically promote tumor growth and angiogenesis Cancer Sci 98 2007 2009 2018
148. Z.G. Fridlender, G. Buchlis, V. Kapoor, G. Cheng, J. Sun, and S. Singhal CCL2 blockade augments cancer immunotherapy Cancer Res 70 2009 109 118
149. M. Takahashi, H. Miyazaki, M. Furihata, H. Sakai, T. Konakahara, and M. Watanabe Chemokine CCL2/MCP-1 negatively regulates metastasis in a highly bone marrow-metastatic mouse breast cancer model Clin Exp Metastasis 26 2009 817 828
150. S. Huang, R.K. Singh, K. Xie, M. Gutman, K.K. Berry, and C.D. Bucana Expression of the JE/MCP-1 gene suppresses metastatic potential in murine colon carcinoma cells Cancer Immunol Immunother 39 1994 231 238
151. S. Huang, K. Xie, R.K. Singh, M. Gutman, and M. Bar-Eli Suppression of tumor growth and metastasis of murine renal adenocarcinoma by syngeneic fibroblasts genetically engineered to secrete the JE/MCP-1 cytokine J Interferon Cytokine Res 15 1995 655 665
152. L. Zhang, T. Yoshimura, and D.T. Graves Antibody to Mac-1 or monocyte chemoattractant protein-1 inhibits monocyte recruitment and promotes tumor growth J Immunol 158 1997 4855 4861
153. P. Monti, B.E. Leone, F. Marchesi, G. Balzano, A. Zerbi, and F. Scaltrini The CC chemokine MCP-1/CCL2 in pancreatic cancer progression: regulation of expression and potential mechanisms of antimalignant activity Cancer Res 63 2003 7451 7461
154. K. Hirose, M. Hakozaki, Y. Nyunoya, Y. Kobayashi, K. Matsushita, and T. Takenouchi Chemokine gene transfection into tumour cells reduced tumorigenicity in nude mice in association with neutrophilic infiltration Br J Cancer 72 1995 708 714
155. M. Nesbit, H. Schaider, T.H. Miller, and M. Herlyn Low-level monocyte chemoattractant protein-1 stimulation of monocytes leads to tumor formation in nontumorigenic melanoma cells J Immunol 166 2001 6483 6490